Abstract:
:Micheliolide (MCL), a sesquiterpene lactone isolated from Michelia compressa and Michelia champaca, has been used previously to inhibit the NF-κB signaling pathway. MCL has exerted various therapeutic effects in numerous types of disease, such as inflammatory and cancer. However, to the best of our knowledge, its underlying anticancer mechanism remains to be understood. The present study aimed to investigate the effects of MCL on human glioma U251MG cells and to determine the potential anticancer mechanism of action of MCL. From Cell Counting Kit-8, colony formation assay, apoptosis assay and Confocal immunofluorescence imaging analysis, the results revealed that MCL significantly inhibited cell viability in vitro and induced cell apoptosis via activation of the cytochrome c/caspase-dependent apoptotic pathway. In addition, MCL also suppressed cell invasion and metastasis via the wound healing and Transwell invasion assays. Furthermore, western blot and reverse transcription PCR analyses demonstrated that MCL significantly downregulated cyclooxygenase-2 (COX-2) expression levels, which may have partially occurred through the inactivation of the NF-κB signaling pathway. In conclusion, the results of the present study indicated that MCL may inhibit glioma carcinoma growth by downregulating the NF-κB/COX-2 signaling pathway, which suggested that MCL may be a novel and alternative antitumor agent for the treatment of human glioma carcinoma.
journal_name
Oncol Lettjournal_title
Oncology lettersauthors
Feng D,Liu M,Liu Y,Zhao X,Sun H,Zheng X,Zhu J,Shang Fdoi
10.3892/ol.2020.11928subject
Has Abstractpub_date
2020-10-01 00:00:00pages
67issue
4eissn
1792-1074issn
1792-1082pii
OL-0-0-11928journal_volume
20pub_type
杂志文章相关文献
Oncology Letters文献大全abstract::The use of bronchoscopy is central to the diagnosis of lung cancer. However, the sensitivity of bronchoscopy is low. In addition, bronchial washing cytology, which is a routine adjunctive test, does not significantly improve the performance of bronchoscopy owing to its low sensitivity. To enhance the diagnostic perfor...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2018.8699
更新日期:2018-07-01 00:00:00
abstract::Pyruvate kinase isoenzyme M2 (PKM2) has previously been identified as a tumor biomarker and as a potential target for cancer therapy. In this study, F§FJ-5, a characterized naphthoquinone modifier of mollugin, was synthesized in order to investigate its anticancer activity and the potential mechanisms. It was observed...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.5522
更新日期:2017-02-01 00:00:00
abstract::Hepatocellular carcinoma (HCC) metastases in the mediastinum are rare, particularly under the arch of the aorta. The present study describes the case of a 30-year-old male patient who presented with back pain and hoarseness for 2 months due to lymph node metastasis of HCC. The patient had undergone right hepatic lobec...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.4687
更新日期:2016-08-01 00:00:00
abstract::Aryl hydrocarbon receptor nuclear translocator (ARNT) is a transcription factor that has been reported to play a vital role in regulating glycolysis, angiogenesis and apoptosis. Recently, ARNT has been reported to a play role in pancreatic-islet function in type 2 diabetes. However, the role of ARNT in kidney cancer h...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2020.11917
更新日期:2020-10-01 00:00:00
abstract::The occurrence of primary carcinoma of the ureteral stump following radical nephrectomy for renal cell carcinoma is extremely rare; 7 patients with the disease have been reported previously. All these patients were males with transitional cell carcinoma. The current study reports the case of a 61-year-old woman, who p...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.4426
更新日期:2016-05-01 00:00:00
abstract::The present study designed a novel preoperative chemoradiotherapy (CRT) with sequential oxaliplatin and irinotecan with S-1 for locally advanced rectal cancer (LARC). This phase I study evaluated the maximum tolerated dose and recommended dose (RD) of oxaliplatin following irinotecan with S-1. Patients with clinical s...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2019.10028
更新日期:2019-04-01 00:00:00
abstract::Extraosseous osteosarcoma originating from paratesticular soft tissue is an extremely rare type of malignant tumor. With the exception of the present study, only one other case of osteosarcoma originating from paratesticular soft tissue has previously been reported. A 52-year-old man presented with a painless scrotal ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.518
更新日期:2012-03-01 00:00:00
abstract::Diagnostic assays for human epidermal growth factor receptor 2 (HER2) expression have a high predictive value because patients with HER2-positive tumors could benefit from HER2-targeted therapy. The aim of the present study is to analyze the incidence of HER2 gene amplification in selected tumors with adverse features...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.5125
更新日期:2016-11-01 00:00:00
abstract::The geldanamycin derivative 17-allylamino-17-demethoxygeldanamycin (17-AAG) is known to induce internalisation and degradation of the otherwise internalisation-resistant human epidermal growth factor receptor 2 (HER2) receptor. In the present study, 17-AAG was used to increase internalisation of the HER2-specific Affi...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.4990
更新日期:2016-10-01 00:00:00
abstract::Targeted therapy of non-small cell lung cancer (NSCLC) patients with mutations in the epidermal growth factor receptor (EGFR) gene has been associated with improved prognosis. However, there is a shortage on data from real-world clinical practice in management of EGFR-positive NSCLC patients in Poland. The present stu...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2017.6907
更新日期:2017-11-01 00:00:00
abstract::The aim of the present study was to investigate the immunohistochemical expression of cluster of differentiation (CD) 34 and vascular endothelial growth factor (VEGF) in breast cancer tissue, and their prognostic significance. High CD34 expression levels (microvessel density, >15/HPF) were identified in 27.3% (12/44) ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2015.3348
更新日期:2015-08-01 00:00:00
abstract::Curcumin (CUR) has been demonstrated to protect against carcinogenesis and to prevent tumor development in cancer; however, the clinical application of CUR is limited by its instability and poor metabolic properties. The present study offers an strategy for a novel CUR analogue, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.5126
更新日期:2016-11-01 00:00:00
abstract::The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retros...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol_00000034
更新日期:2010-01-01 00:00:00
abstract::The epidermal growth factor receptor (EGF-R) signaling pathway is thought to have an important role in the development and progression of several carcinomas, as it is associated with cell proliferation, differentiation and migration. Activation of EGF-R signaling regulates epithelial-mesenchymal transition (EMT)-assoc...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.5406
更新日期:2017-01-01 00:00:00
abstract::Inhibition of nuclear factor-κB (NF-κB) results in antitumor activity in leukemia cells, and may be a potential therapeutic strategy for the treatment of leukemia. However, a significant limitation of NF-κB inhibition in the treatment of leukemia is the low efficiency of this technique. NF-κB inhibitor treatment induc...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2015.3786
更新日期:2015-12-01 00:00:00
abstract::Bortezomib is approved for treating relapsed multiple myeloma (MM) and mantle cell lymphoma, and clinical evidence has shown complete clinical responses in MM patients. Peripheral neuropathy is one of the most common adverse effects of bortezomib. However, rare evidence has shown that bortezomib is associated with Gui...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2015.3634
更新日期:2015-11-01 00:00:00
abstract::The aim of the present study was to identify monitoring and prevention measures as well as predictive factors for early detection of renal toxicity associated with long-term administration of adefovir dipivoxil in order to avoid progression to Fanconi syndrome. Clinical data of 28 patients with Fanconi syndrome caused...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.5393
更新日期:2017-01-01 00:00:00
abstract::Some colorectal cancer liver metastases (CLMs) disappear on serial imaging during chemotherapy and the optimal treatment strategy for such lesions remains undetermined. The purpose of this study was to investigate the outcome in disappearing CLMs, as few studies have focused on this topic, with conflicting results. Am...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.842
更新日期:2012-11-01 00:00:00
abstract::Xeroderma pigmentosum variant (XP-V) is a subtype of xeroderma pigmentosum (XP) disease with typical pigmentation and types of cancer in the oral maxillofacial and other sun-exposed regions. Few factors of tumor proneness in XP-V have been completely elucidated with the exception of the POLH [which encodes DNA polymer...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2013.1604
更新日期:2013-12-01 00:00:00
abstract::The aim of the present study was to determine the usefulness of the positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) in the detection of recurrence or metastasization of differentiated thyroid carcinoma (DTC) in patients with abnormal thyroglobulin levels and negative finding...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.4229
更新日期:2016-04-01 00:00:00
abstract::MicroRNA (miRNA or miR)-298 has been reported to be downregulated and to modify the expression of the polycomb protein enhancer of zeste 2 (EZH2) in recurrent epithelial ovarian cancer (EOC). To date, no functional evidence of a miR-298-EZH2 axis in EOC has been documented. The present study aimed to investigate the a...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2016.5204
更新日期:2016-11-01 00:00:00
abstract::The liver kinase B1 (LKB1)/5'-adenosine monophosphate-activated protein kinase pathway has been reported to facilitate glioma cell growth by improving growth conditions. To investigate the clinical significance of LKB1 in human gliomas western blot analysis and quantitative polymerase chain reaction experiments were p...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2017.5631
更新日期:2017-03-01 00:00:00
abstract::The aim of this study was to investigate the effect of dexmedetomidine (Dex) on the respiratory function during anesthesia induction in pediatric patients undergoing retinoblastoma (RB) resection. A total of 87 pediatric patients who underwent RB resection in Yidu Central Hospital of Weifang were recruited into this s...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2019.9893
更新日期:2019-03-01 00:00:00
abstract::The traditional Chinese medicine Jinfukang (JFK) has been shown as a valuable drug to treat non-small cell lung cancer (NSCLC). Previously, it was reported that JFK-induced epigenetic alteration is involved in anti-lung cancer activity. In the present study, the effect of JFK on lung cancer cell lines was examined wit...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2018.9149
更新日期:2018-10-01 00:00:00
abstract::Point mutation of the BRAF gene is a genetic event that occurs in a subset of lung adenocarcinoma cases. For example, BRAF V600E is a driver mutation that can be effectively targeted using selective BRAF and/or MEK inhibitors. The present study hypothesized that an increase in BRAF copy number may be correlated with c...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2014.2719
更新日期:2015-02-01 00:00:00
abstract::The outcomes of matched unrelated donor (MUD) hematopoietic stem cell transplantation (HSCT) and immunosuppressive therapy (IST) in patients with severe aplastic anemia (SAA) remain controversial. The clinical outcome in patients that undergo transplantation following failed IST is typically poorer when compared with ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2014.2341
更新日期:2014-10-01 00:00:00
abstract::Reactive nodular fibrous pseudotumor (RNFP) is a tumor-like lesion that is characterized by reactive fibroblast/myofibroblast proliferation within collagenic hyalinized stroma, due to its association with injury or inflammation. The current study describes the case of a 60-year-old female with a history of abdominal s...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2015.2882
更新日期:2015-03-01 00:00:00
abstract::Receptor of activated C Kinase 1 (RACK1) is an essential scaffold and anchoring protein, which serves an important role in multiple tumorigenesis signaling pathways. The present study aimed to investigate the expression of RACK1 in gastric cancer (GC), and its association with the occurrence and development of GC. In ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2017.6741
更新日期:2017-10-01 00:00:00
abstract::The phosphoinositide-3 kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway is a cellular pathway involved in cell growth, tumorigenesis and cell invasion which is frequently activated in various types of cancer. The downstream effector of the pathway is mTOR which is important in cellular growth and homeost...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.930
更新日期:2012-12-01 00:00:00
abstract::Research on the immunosuppression of cancer cells has attracted much attention in recent years. The present study sought to provide a new strategy for tumor immunotherapy targeting mast cells by studying the mechanisms underlying mast cell function in cancer immunosuppression. Between January 2015 and December 2017, t...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2020.12224
更新日期:2020-12-01 00:00:00